© 2022 MJH Life Sciences and Center for Biosimilars®. All rights reserved.
© 2022 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Robert Spina, MBA, is vice president of Marketing, Market Access, and Patient Services at Sandoz.
May 29, 2021
Changes in federal and state policy can help liberate the savings potential in biosimilars and broaden investment in our health care system.